These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15823673)

  • 1. Benefits of FK506 (tacrolimus) for residual, cyclosporin- and prednisone-resistant myasthenia gravis: one-year follow-up of an open-label study.
    Ponseti JM; Azem J; Fort JM; Codina A; Montoro JB; Armengol M
    Clin Neurol Neurosurg; 2005 Apr; 107(3):187-90. PubMed ID: 15823673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis.
    Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Gamez J; Armengol M
    Curr Med Res Opin; 2006 May; 22(5):885-95. PubMed ID: 16709310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
    Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Cervera C; Armengol M
    Neurology; 2005 May; 64(9):1641-3. PubMed ID: 15883336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study.
    Ponseti JM; Gamez J; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Armengol M
    Curr Med Res Opin; 2007 Jun; 23(6):1269-78. PubMed ID: 17559724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term therapeutic efficacy and safety of low-dose tacrolimus (FK506) for myasthenia gravis.
    Tada M; Shimohata T; Tada M; Oyake M; Igarashi S; Onodera O; Naruse S; Tanaka K; Tsuji S; Nishizawa M
    J Neurol Sci; 2006 Aug; 247(1):17-20. PubMed ID: 16631797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus in refractory patients with myasthenia gravis: coadministration and tapering of oral prednisolone.
    Shimojima Y; Matsuda M; Gono T; Ishii W; Tokuda T; Ikeda S
    J Clin Neurosci; 2006 Jan; 13(1):39-44. PubMed ID: 16307880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus for myasthenia gravis: a clinical study of 212 patients.
    Ponseti JM; Gamez J; Azem J; López-Cano M; Vilallonga R; Armengol M
    Ann N Y Acad Sci; 2008; 1132():254-63. PubMed ID: 18096852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and immunological impact of tacrolimus in Chinese patients with generalized myasthenia gravis.
    Zhao CB; Zhang X; Zhang H; Hu XQ; Lu JH; Lu CZ; Xiao BG
    Int Immunopharmacol; 2011 Apr; 11(4):519-24. PubMed ID: 21195813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?
    Sekine Y; Kawaguchi N; Hamada C; Sekiguchi H; Yasufuku K; Iyoda A; Shibuya K; Fujisawa T
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):908-13. PubMed ID: 16675232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year follow-up with low-dose tacrolimus in patients with myasthenia gravis.
    Minami N; Fujiki N; Doi S; Shima K; Niino M; Kikuchi S; Sasaki H
    J Neurol Sci; 2011 Jan; 300(1-2):59-62. PubMed ID: 21035148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis.
    Ponseti JM; Gamez J; Vilallonga R; Ruiz C; Azem J; López-Cano M; Armengol M
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):1062-7. PubMed ID: 18760934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of low-dose FK506 in the treatment of Myasthenia gravis--a randomized pilot study.
    Nagane Y; Utsugisawa K; Obara D; Kondoh R; Terayama Y
    Eur Neurol; 2005; 53(3):146-50. PubMed ID: 15900097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose tacrolimus for two cases of myasthenia gravis with invasive thymoma that relapsed shortly after thymectomy.
    Tsukaguchi M; Shimamura M; Ikeda K; Urai Y; Sasaki I; Deguchi K; Touge T; Takeuchi H; Kuriyama S
    J Neurol Sci; 2005 Apr; 231(1-2):85-8. PubMed ID: 15792826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy of low-dose tacrolimus and prednisone in nephrotic syndrome with slight mesangial proliferation.
    Miao L; Sun J; Yuan H; Jia Y; Xu Z
    Nephrology (Carlton); 2006 Oct; 11(5):449-54. PubMed ID: 17014560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone.
    Liu C; Gui M; Cao Y; Lin J; Li Y; Ji S; Bu B
    Pediatr Neurol; 2017 Dec; 77():42-47. PubMed ID: 29074055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
    Li X; Li H; Chen J; He Q; Lv R; Lin W; Li Q; He X; Qu L; Suya W
    Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transsternal thymectomy for myasthenia gravis: surgical outcome.
    Kattach H; Anastasiadis K; Cleuziou J; Buckley C; Shine B; Pillai R; Ratnatunga C
    Ann Thorac Surg; 2006 Jan; 81(1):305-8. PubMed ID: 16368387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis.
    De Feo LG; Schottlender J; Martelli NA; Molfino NA
    Muscle Nerve; 2002 Jul; 26(1):31-6. PubMed ID: 12115946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of FK506 on myasthenia gravis patients with high interleukin-2 productivity in peripheral blood mononuclear cells.
    Utsugisawa K; Nagane Y; Yonezawa H; Obara D; Kondoh R; Tohgi H
    Muscle Nerve; 2003 Feb; 27(2):245-8. PubMed ID: 12548534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effect of tacrolimus on myasthenia gravis with thymoma.
    Mitsui T; Kunishige M; Ichimiya M; Shichijo K; Endo I; Matsumoto T
    Neurologist; 2007 Mar; 13(2):83-6. PubMed ID: 17351528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.